Clinical Trial Update: Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans [Phase 3]

View source ↗

Summary

This Phase 3 trial investigates whether liraglutide influences brown adipose tissue activity in adults with obesity and type 2 diabetes; the study status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Obesity, Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN